NASDAQ:AGRX
$0.230
(
-4.96%
)
Friday, 24th Mar 2023
Agile Therapeutics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.200 | $0.290 | Friday, 24th Mar 2023 AGRX stock ended at $0.230. This is 4.96% less than the trading day before Thursday, 23rd Mar 2023. During the day the stock fluctuated 10.98% from a day low at $0.211 to a day high of $0.235. |
| 90 days | $0.184 | $0.320 | |
| 52 weeks | $0.110 | $4.37 |
Historical Agile Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2022-03-25 | $0.270 | $0.275 | $0.253 | $0.265 | 705 600 |
| 2022-03-24 | $0.276 | $0.276 | $0.265 | $0.275 | 428 700 |
| 2022-03-23 | $0.277 | $0.277 | $0.263 | $0.265 | 389 000 |
| 2022-03-22 | $0.280 | $0.280 | $0.264 | $0.270 | 458 137 |
| 2022-03-21 | $0.268 | $0.280 | $0.262 | $0.270 | 478 727 |
| 2022-03-18 | $0.260 | $0.270 | $0.256 | $0.268 | 853 761 |
| 2022-03-17 | $0.240 | $0.259 | $0.240 | $0.256 | 699 100 |
| 2022-03-16 | $0.252 | $0.252 | $0.235 | $0.247 | 671 900 |
| 2022-03-15 | $0.225 | $0.250 | $0.222 | $0.240 | 1 121 500 |
| 2022-03-14 | $0.235 | $0.245 | $0.219 | $0.237 | 1 396 400 |
| 2022-03-11 | $0.277 | $0.278 | $0.258 | $0.260 | 847 500 |
| 2022-03-10 | $0.280 | $0.280 | $0.257 | $0.278 | 490 200 |
| 2022-03-09 | $0.260 | $0.282 | $0.247 | $0.280 | 1 313 900 |
| 2022-03-08 | $0.255 | $0.259 | $0.233 | $0.255 | 1 510 300 |
| 2022-03-07 | $0.280 | $0.291 | $0.250 | $0.253 | 2 395 800 |
| 2022-03-04 | $0.280 | $0.300 | $0.280 | $0.280 | 443 800 |
| 2022-03-03 | $0.300 | $0.309 | $0.270 | $0.276 | 618 800 |
| 2022-03-02 | $0.305 | $0.310 | $0.290 | $0.290 | 527 700 |
| 2022-03-01 | $0.320 | $0.330 | $0.295 | $0.302 | 526 700 |
| 2022-02-28 | $0.283 | $0.320 | $0.283 | $0.306 | 336 900 |
| 2022-02-25 | $0.298 | $0.320 | $0.283 | $0.308 | 762 900 |
| 2022-02-24 | $0.254 | $0.298 | $0.251 | $0.296 | 900 400 |
| 2022-02-23 | $0.294 | $0.294 | $0.280 | $0.281 | 633 600 |
| 2022-02-22 | $0.310 | $0.317 | $0.283 | $0.285 | 645 100 |
| 2022-02-18 | $0.302 | $0.317 | $0.290 | $0.307 | 640 800 |
| 2022-02-17 | $0.339 | $0.340 | $0.301 | $0.307 | 805 700 |
| 2022-02-16 | $0.339 | $0.339 | $0.314 | $0.319 | 825 600 |
| 2022-02-15 | $0.334 | $0.338 | $0.310 | $0.334 | 577 200 |
| 2022-02-14 | $0.306 | $0.319 | $0.301 | $0.310 | 385 600 |
| 2022-02-11 | $0.335 | $0.339 | $0.305 | $0.315 | 646 400 |
| 2022-02-10 | $0.330 | $0.350 | $0.321 | $0.332 | 741 800 |
| 2022-02-09 | $0.330 | $0.336 | $0.326 | $0.334 | 469 400 |
| 2022-02-08 | $0.341 | $0.365 | $0.320 | $0.320 | 814 900 |
| 2022-02-07 | $0.355 | $0.380 | $0.338 | $0.341 | 575 500 |
| 2022-02-04 | $0.346 | $0.361 | $0.338 | $0.350 | 331 500 |
| 2022-02-03 | $0.363 | $0.370 | $0.332 | $0.339 | 794 900 |
| 2022-02-02 | $0.380 | $0.380 | $0.355 | $0.368 | 529 500 |
| 2022-02-01 | $0.350 | $0.389 | $0.346 | $0.378 | 1 034 000 |
| 2022-01-31 | $0.317 | $0.390 | $0.313 | $0.349 | 1 245 300 |
| 2022-01-28 | $0.290 | $0.339 | $0.290 | $0.326 | 1 658 700 |
| 2022-01-27 | $0.319 | $0.328 | $0.291 | $0.294 | 1 326 800 |
| 2022-01-26 | $0.331 | $0.337 | $0.300 | $0.305 | 980 300 |
| 2022-01-25 | $0.318 | $0.339 | $0.300 | $0.330 | 755 600 |
| 2022-01-24 | $0.280 | $0.326 | $0.280 | $0.321 | 2 123 300 |
| 2022-01-21 | $0.345 | $0.349 | $0.295 | $0.300 | 2 159 300 |
| 2022-01-20 | $0.350 | $0.366 | $0.333 | $0.335 | 1 339 200 |
| 2022-01-19 | $0.362 | $0.370 | $0.337 | $0.342 | 1 387 000 |
| 2022-01-18 | $0.385 | $0.385 | $0.360 | $0.360 | 1 123 600 |
| 2022-01-14 | $0.410 | $0.420 | $0.358 | $0.380 | 2 117 800 |
| 2022-01-13 | $0.400 | $0.435 | $0.392 | $0.397 | 2 682 400 |
About Agile Therapeutics
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to h... AGRX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
